Patent US4289764A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4289764A Expired / Lapsed US ⏱️ 0.0 years remaining

Steroid compositions

Assignee: Drythanol Ltd
•
Filing: 1979-12-04
•
Granted: 1981-09-15
•
Expires: 1999-12-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a pharmaceutical composition for topical application comprising an essentially saturated solution of hydrocortisone in aqueous propylene glycol solution containing at least 15% but less than 50% by weight of propylene glycol, the proportion of hydrocortisone in the total composition being at least 0.08% but not greater than 0.4% by weight of aqueous propylene glycol and from 0.025 to 0.4% based on the total weight of the composition, the said composition being characterized by a pH in the range of 2.7 to 3.3, and the substantial absence of metallic cations. Such compositions have excellent storage stability and surprisingly high effectiveness of the hydrocortisone contained therein.

Inventors

  • 👤 Hyman Yarrow
  • 👤 Martin Whitefield

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 14:52
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/12; A61K9/00; A61K9/0012; A61K9/0014

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 109 words
In a pharmaceutical composition for topical application comprising an essentially saturated solution of hydrocortisone in an aqueous propylene glycol solution containing at least 15% but less than 50% by weight of propylene glycol, the proportion of hydrocortisone in the total composition being at least 0.08% but not greater than 0.4% by weight of aqueous propylene glycol and from 0.025 to 0.4% based on the total weight of the composition, the improvement which consists in including in the composition sufficient of a pharmacologically acceptable compatible non-toxic acid to bring the pH of the composition to within the range 2.7 to 3.3, and in substantially excluding metallic cations from the composition.
Claim 2
Dependent Claim 109 words
In a pharmaceutical composition for topical application comprising an essentially saturated solution of hydrocortisone in an aqueous propylene glycol solution containing at least 15% but less than 50% by weight of propylene glycol, the proportion of hydrocortisone in the total composition being at least 0.08% but not greater than 0.4% by weight of aqueous propylene glycol and from 0.025 to 0.4% based on the total weight of the composition, the improvement which consists in including in the composition sufficient of a pharmacologically acceptable compatible non-toxic acid to bring the pH of the composition to within the range 2.7 to 3.3, and in substantially excluding metallic cations from the composition.
Claim 3
Dependent Claim 21 words
The improvement of claim 1 in which the said acid is an aqueous carboxylic acid which is also a chelating agent.
Claim 4
Dependent Claim 13 words
The improvement of claim 1 in which the said acid is citric acid.
Claim 5
Dependent Claim 37 words
A pharmaceutical composition for topical application consisting essentially of hydrocortisone 0.05 to 0.3%, propylene glycol about 20%, emulsifying ointment BP about 40%, water about 40%, and sufficient citric acid to adjust the pH to 2.7 to 3.3.
Claim 6
Dependent Claim 37 words
A pharmaceutical composition for topical application consisting essentially of hydrocortisone 0.05 to 0.3%, propylene glycol about 20%, emulsifying ointment BP about 40%, water about 40%, and sufficient citric acid to adjust the pH to 2.7 to 3.3.

References Cited (Backward Citations)

US3899580A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-09-14 1985-03-16 1985-09-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-09-14 1989-03-16 1989-09-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-09-14 1993-03-16 1993-09-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag